Related Experiment Videos
[Lyell's syndrome in an AIDS patient]
S Quintas1, G do Carmo, R Gama
1Serviço de Doenças Infecciosas, Hospital de Santa Maria, Lisboa.
Acta Medica Portuguesa
|June 1, 1997
Summary
Toxic epidermal necrolysis (TEN) is a severe drug reaction, increasingly seen in advanced HIV. This case highlights diagnostic and treatment challenges, especially with prior adverse drug reactions.
Area of Science:
- Dermatology
- Immunology
- Pharmacology
Background:
- Toxic epidermal necrolysis (TEN), also known as Lyell's syndrome, is a rare but severe mucocutaneous reaction, often drug-induced.
- It is characterized by extensive skin detachment and severe systemic symptoms, with a high mortality rate (20-66%).
- The incidence of TEN is notably increasing in patients with advanced HIV infection.
Observation:
- The diagnosis of TEN is primarily clinical, as reliable tests to identify the causative drug are lacking.
- A case of TEN in an AIDS patient is presented, illustrating diagnostic and therapeutic complexities.
- This patient had a history of adverse drug reactions (ADRs), complicating the management of co-existing conditions.
Findings:
- The pathophysiology of TEN involves immune mechanisms, altered drug metabolism, and genetic factors.
- Managing patients with TEN and a history of ADRs poses challenges regarding drug reintroduction.
- HIV-infected individuals face an elevated risk of severe cutaneous ADRs, including TEN.
Implications:
- There is a critical need for improved diagnostic tools for drug-induced TEN.
- New guidelines are essential for the early diagnosis and management of TEN in HIV patients.
- Careful therapeutic strategies are required to balance treating active disorders and avoiding further severe cutaneous adverse drug reactions.